The global market for biological and medical imaging reagents is expected to grow from $26.6 billion in 2025 to $40.1 billion by 2030, with a CAGR of 8.6%. The report analyzes market trends, technologies, and key players, highlighting the increased demand for advanced imaging reagents in the healthcare industry.

Factors driving market growth include increased R&D funding, the rise in chronic diseases, and the growth of personalized medicine. The demand for advanced imaging reagents is accelerating, especially with the integration of AI into medical imaging and the development of next-generation reagents.

AI is revolutionizing imaging reagents, enabling faster and more accurate diagnostic imaging interpretation. The market is projected to reach $40.1 billion by 2030, driven by factors like R&D investments, chronic disease prevalence, and personalized medicine adoption.

The market is segmented by type, modality, technology, application, end user, and region, with contrast reagents expected to dominate through 2030. North America accounted for 42.5% of the market in 2024, with key players including Agilent Technologies, Bayer AG, and GE Healthcare.

For further information or to purchase the full report, contact BCC Research. Their market research reports provide unbiased analysis to help make informed business decisions. Visit their media page for access to their market research library.

Read more at GlobeNewswire: Global Market for Biological and Medical Imaging Reagents